(Q53337125)

13 May 2018

title

Comparative effectiveness of general practitioner versus pharmacist dosing of patients requiring anticoagulation in the community. (English)

1 reference

13 May 2018

1 reference

Holden J

1

1 reference

13 May 2018

Holden K

series ordinal

2

1 reference

13 May 2018

publication date

1 February 2000

1 reference

13 May 2018

Journal of Clinical Pharmacy and Therapeutics

published in

1 reference

13 May 2018

volume

25

1 reference

13 May 2018

issue

1

1 reference

13 May 2018

page(s)

49-54

1 reference

13 May 2018

Management of venous thromboembolism

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00262.X

Prevalence of atrial fibrillation and eligibility for anticoagulants in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00262.X

Cost-justification of a clinical pharmacist-managed anticoagulation clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00262.X

Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00262.X

Audit of anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00262.X

Fortnightly review: anticoagulation in heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00262.X

Antithrombotic Therapy in Valvular Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2710.2000.00262.X

10.1046/J.1365-2710.2000.00262.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018